abstract |
The present disclosure relates to immunotherapy of diseases (eg, cancer) using fusion proteins in combination with anti-chemical repellents. In particular, the fusion protein comprises an antigen binding domain (eg, an antibody or antibody fragment) and a stress protein domain. [Selection] Figure 1 |